Your browser doesn't support javascript.
loading
Rapid Organoid Reconstitution by Chemical Micromolding.
Weber, Robert J; Cerchiari, Alec E; Delannoy, Lucas S; Garbe, James C; LaBarge, Mark A; Desai, Tejal A; Gartner, Zev J.
Afiliação
  • Weber RJ; Department of Pharmaceutical Chemistry, University of California, San Francisco, 600 16th Street, San Francisco, California 94158, United States.
  • Cerchiari AE; Chemistry and Chemical Biology Graduate Program, University of California, San Francisco, 600 16th Street, Room 522, San Francisco, California 94158, United States.
  • Delannoy LS; Medical Scientist Training Program, University of California, San Francisco, 513 Parnassus Avenue, San Francisco, California 94143, United States.
  • Garbe JC; Department of Pharmaceutical Chemistry, University of California, San Francisco, 600 16th Street, San Francisco, California 94158, United States.
  • LaBarge MA; UC Berkeley-UCSF Group in Bioengineering, 1700 Fourth Street, Room 216, San Francisco, California 94158, United States.
  • Desai TA; UCSF Bioengineering and Therapeutic Sciences, 1700 Fourth Street, Room 216B, San Francisco, California 94158, United States.
  • Gartner ZJ; Laboratory of Stem Cell Bioengineering, Institute of Bioengineering, École Polytechnique Fédérale de Lausanne, Station 15, Building Al 1106, CH-1015 Lausanne, Switzerland.
ACS Biomater Sci Eng ; 2(11): 1851-1855, 2016 Nov 14.
Article em En | MEDLINE | ID: mdl-33440521
ABSTRACT
Purified populations of cells can be reconstituted into organoids that recapitulate aspects of their in vivo structure and function. These organoids are useful as models of healthy and diseased tissue in the basic sciences, in vitro screens, and regenerative medicine. Existing strategies to reconstitute organoids from purified cells face obstacles with respect to cell-viability, multicellular connectivity, scalability, and compatibility with subsequent experimental or analytical techniques. To address these challenges, we developed a strategy for rapidly casting populations of cells into microtissues of prescribed size and shape. This approach begins by chemically remodeling the adhesive properties of living cells with membrane-anchored ssDNA with modest annealing kinetics. Populations of complementary labeled cells are then combined into microwells that rapidly mold the DNA-adhesive cell populations into 3D aggregates of uniform size and shape. Once formed, aggregates are removed from the molds in the presence of "capping" oligonucleotides that block hybridization of residual surface DNA between aggregates in suspension. Finally, transfer of aggregates to biomimetic gels for 3D culture completes the process of reconstitution. This strategy of chemical micromolding allows for control over aggregate internal topology and does not perturb the natural process of self-organization in primary human mammary epithelial cells.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2016 Tipo de documento: Article